SCHEMBL5929011

SCHEMBL5929011

CCCCn1c(-c2ccccc2C)nc(Cl)c1CN1CCCCC1c1ccc(OC)c(C)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ CD274 Q9NZQ7 3/20 0.35
▸ PDCD1LG2 Q9BQ51 1/20 0.35
▸ KDM4E B2RXH2 5/20 0.35
▸ MAPT P10636 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ CFB P00751 3/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ PDCD1 Q15116 2/20 0.34
▸ CRHBP P24387 1/20 0.33
▸ CRHR2 Q13324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929255 0.92 KMT2A (0.38) KMT2AMEN1LMNAPOLBTDP1
SCHEMBL5929026 0.91 KDM4E (0.38) KMT2AMEN1LMNAPOLBTDP1
SCHEMBL5929361 0.91 KDM4E (0.43) KMT2AMEN1LMNADRD2DRD3
SCHEMBL5929140 0.88 SMN1; SMN2 (0.38) KMT2AMEN1LMNADRD2DRD3
SCHEMBL5929224 0.85 SMN1; SMN2 (0.40) KMT2AMEN1LMNADRD2DRD3
SCHEMBL5928918 0.85 KDM4E (0.46) KMT2AMEN1LMNAPOLBDRD2
SCHEMBL5928957 0.82 MEN1 (0.44) KMT2AMEN1LMNACYP2D6KDM4E
SCHEMBL5929045 0.81 KDM4E (0.39) KMT2AMEN1LMNAPOLBTDP1
SCHEMBL5929025 0.80 CFB (0.37) KMT2AMEN1CYP3A4CYP2D6KCNH2
SCHEMBL5929161 0.80 CYP3A4 (0.36) KMT2AMEN1LMNATDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators C5AR1, C5AR2, C3AR1 KMT2A 2955/4885MEN1 2791/4885LMNA 4776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback